Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on June 3, 2025
Vanqua Bio to Present at Upcoming Scientific Conferences
GlobeNewswire
·
June 3, 2025
CHICAGO, June 03, 2025 (GLOBE NEWSWIRE) -- Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present interim Phase 1 data for its lead clinical program, VQ-101, at two upcoming scientific conferences – the GBA1 Meeting …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 3, 2025
RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted seven newly-hired employees restricted stock units (RSUs) …
OXB Highlights the Launch of its Innovation and Technology Excellence Board
GlobeNewswire
·
June 3, 2025
Oxford, UK – 03 June 2025: OXB (LSE: OXB) (“the Company”), a global quality and innovation-led cell and gene therapy CDMO, today highlights the launch of its Innovation and Technology Excellence Board (ITEB). The ITEB brings together leading experts in …
Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that …
Transpire Bio Enters into Exclusive License Agreement with Suzhou Intragrand Pharma for Investigational PDE4 Inhibitor
GlobeNewswire
·
June 3, 2025
SUNRISE, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- Transpire Bio Inc., a U.S.-based, integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has signed an …
Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
SOUTH SAN FRANCISCO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …
Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
GlobeNewswire
·
June 3, 2025
BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the appointment of Maha Radhakrishnan, M.D., to its Board of Directors. “We are pleased to have Dr. Radhakrishnan join the Board at this time of tremendous …
I-Mab to Participate in the H.C. Wainwright “HCW@Home” Series
GlobeNewswire
·
June 3, 2025
ROCKVILLE, Md., June 03, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s …
Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
GlobeNewswire
·
June 3, 2025
WILMETTE, Ill., June 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today …
FactSet Announces CEO Succession Plan
GlobeNewswire
·
June 3, 2025
Sanoke Viswanathan Appointed Chief Executive Officer Effective Early September 2025 Phil Snow to Retire After Accomplished 30-Year Career with FactSet, Including 10 Years as CEO NORWALK, Conn., June 03, 2025 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: …
New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve
GlobeNewswire
·
June 3, 2025
PRINCETON, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced the publication of a post-hoc analysis of data from the ERT-experienced cohort of the PROPEL study of cipaglucosidase alfa-atga + miglustat (cipa+mig) in …
Xtract One Announces Updates on One Gateway Launch
GlobeNewswire
·
June 3, 2025
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) a leading technology-driven threat detection and security solution company that prioritizes the patron access …
BeyondSpring Presents Efficacy/Safety Data from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 3, 2025
Median PFS at 6.8 months, Disease Control Rate of 77.3%, 15 months OS% at 78% in Metastatic NSCLC Patients after Progression on PD-1/L1 Therapies FLORHAM PARK, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the …
Bio-Path Holdings Provides Clinical and Operational Update
GlobeNewswire
·
June 3, 2025
HOUSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer and obesity …
QuantaSing to Report Third Fiscal Quarter Financial Results on June 6, 2025
GlobeNewswire
·
June 3, 2025
BEIJING, June 03, 2025 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading lifestyle solution provider empowering adults to live better and longer, today announced that it plans to release its unaudited …
Telix Investor Day in New York City on June 11, 2025: Presenting KOLs
GlobeNewswire
·
June 3, 2025
MELBOURNE, Australia and INDIANAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) provides further details on the agenda for the Company’s Investor Day to be held on Wednesday, June 11, …
La recommandation personnalisée de produits : un levier e-merchandising pour convertir et fidéliser ses clients
GlobeNewswire
·
June 3, 2025
Recommander un produit, c’est bien plus qu’afficher une liste d’articles associés. C’est proposer, au bon moment et au bon endroit, des suggestions réellement pertinentes pour chaque visiteur. Mais qu’entend-on par pertinence ? Dans le cadre du e-commerce, …
MYPE lance une offre de formation sur Microsoft Fabric
GlobeNewswire
·
June 3, 2025
Déjà reconnue pour ses formations sur Microsoft Power BI, la société de consulting et de formation basée à Paris lance désormais une offre d’accompagnement sur la technologie Fabric, plateforme dont Power BI est l’élément phare. Concrètement, l’entreprise …
Goliath Confirms Multiple Occurrences Of Visible Gold Over A 26 Meter Interval From Newly Identified RIRG Feeder Dyke On Surebet High-Grade Gold Discovery That Remains Wide Open, Golddigger Property, Golden Triangle, B.C.
GlobeNewswire
·
June 3, 2025
In 2024, 13 holes were relogged from the same series of Eocene intrusive granitoid dykes that had visible gold (seen with the naked eye) in 6 of the holes and assayed up to 12.03 g/t AuEq over 10 meters (~true width). Additional intervals of gold …
Cogility Launches Cogynt Availability in AWS Marketplace
GlobeNewswire
·
June 3, 2025
IRVINE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Cogility, a leader in Expert AI-powered decision intelligence software for augmented decision support, today announced that Cogynt is now available in AWS Marketplace, a digital catalog that helps you find, …